2019年06月16日 15:56

Komatsu-Fujii T, Nomura M, Otsuka A, Ishida Y, Doi K, Matsumoto S, Muto M, Kabashima K.
Response to imatinib in vaginal melanoma with KIT p.Val559Gly mutation previously treated with nivolumab, pembrolizumab and ipilimumab.
J Dermatol. 2019 Jun;46(6):e203-e204.